Resmed (RMD) Liabilities and Shareholders Equity (2010 - 2026)
Resmed's Liabilities and Shareholders Equity was $8.97 billion in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 9.7% from $8.17 billion a year earlier and up 2.1% from the prior quarter.
Powered by 
Analysis
Resmed (RMD) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
From fiscal Q4 2010 onward, Resmed has reported Liabilities and Shareholders Equity for 65 quarters.
- Liabilities and Shareholders Equity has now increased for eight consecutive fiscal years, with a five-year compound annual growth rate of 13.7% (FY2021 to FY2026).
- In earlier fiscal years, Liabilities and Shareholders Equity was $8.17 billion in FY2025 (+18.9%), $6.87 billion in FY2024 (+1.8%), $6.75 billion in FY2023 (+32.5%) and $5.1 billion in FY2022 (+7.8%).
- The fiscal Q4 2026 figure marks the highest quarterly Liabilities and Shareholders Equity in data going back to fiscal Q4 2010.
- Compared with a year earlier, Liabilities and Shareholders Equity has increased for 31 straight quarters, with growth averaging 12.6% over the last eight quarters.
- The year-over-year growth in Liabilities and Shareholders Equity has ranged between 1.5% (fiscal Q3 2024) and 41.0% (fiscal Q2 2023) over the last five years.
- Per Business Quant data, RMD's Liabilities and Shareholders Equity in the three fiscal quarters before Q4 2026 was $8.78 billion (Q3 2026), $8.5 billion (Q2 2026) and $8.31 billion (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.71 Bn | 229.74 Bn | 4.88 Bn | 113.17 Bn |
| 2 | Abbott Laboratories | 178.38 Bn | 148.81 Bn | 7.27 Bn | 109.22 Bn |
| 3 | Danaher | 161.61 Bn | 145.42 Bn | 3.61 Bn | 92.37 Bn |
| 4 | Intuitive Surgical | 154.15 Bn | 134.44 Bn | 2.08 Bn | 19.35 Bn |
| 5 | Medtronic | 123.21 Bn | 88.46 Bn | 6.34 Bn | 93.31 Bn |
| 6 | Stryker | 117.50 Bn | 103.61 Bn | 4.50 Bn | 47.93 Bn |
| 7 | Boston Scientific | 67.50 Bn | 62.26 Bn | 3.85 Bn | 45.22 Bn |
| 8 | Becton Dickinson | 54.80 Bn | 51.95 Bn | 2.32 Bn | 50.73 Bn |
| 9 | Edwards Lifesciences | 51.78 Bn | 35.79 Bn | 1.35 Bn | 13.87 Bn |
| 10 | Resmed | 36.78 Bn | 30.84 Bn | 861.22 Mn | 8.97 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.97 Bn |
| Mar 31, 2026 | 8.78 Bn |
| Dec 31, 2025 | 8.50 Bn |
| Sep 30, 2025 | 8.31 Bn |
| Jun 30, 2025 | 8.17 Bn |
| Mar 31, 2025 | 7.57 Bn |
| Dec 31, 2024 | 7.14 Bn |
| Sep 30, 2024 | 7.22 Bn |
| Jun 30, 2024 | 6.87 Bn |
| Mar 31, 2024 | 6.81 Bn |
| Dec 31, 2023 | 6.91 Bn |
| Sep 30, 2023 | 6.74 Bn |
| Jun 30, 2023 | 6.75 Bn |
| Mar 31, 2023 | 6.71 Bn |
| Dec 31, 2022 | 6.68 Bn |
| Sep 30, 2022 | 5.18 Bn |
| Jun 30, 2022 | 5.10 Bn |
| Mar 31, 2022 | 4.91 Bn |
| Dec 31, 2021 | 4.73 Bn |
| Sep 30, 2021 | 4.73 Bn |
API Access
Resmed Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "RMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();